Cargando…
Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality
BACKGROUND: COVID-19 vaccines have been approved and made available. While questions of vaccine allocation strategies have received significant attention, important questions remain regarding the potential impact of the vaccine given uncertainties regarding efficacy against transmission, availabilit...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072137/ https://www.ncbi.nlm.nih.gov/pubmed/33937734 http://dx.doi.org/10.1016/j.eclinm.2021.100863 |
_version_ | 1783683859754254336 |
---|---|
author | Haghpanah, Fardad Lin, Gary Levin, Simon A. Klein, Eili |
author_facet | Haghpanah, Fardad Lin, Gary Levin, Simon A. Klein, Eili |
author_sort | Haghpanah, Fardad |
collection | PubMed |
description | BACKGROUND: COVID-19 vaccines have been approved and made available. While questions of vaccine allocation strategies have received significant attention, important questions remain regarding the potential impact of the vaccine given uncertainties regarding efficacy against transmission, availability, timing, and durability. METHODS: We adapted a susceptible-exposed-infectious-recovered (SEIR) model to examine the potential impact on hospitalization and mortality assuming increasing rates of vaccine efficacy, coverage, and administration. We also evaluated the uncertainty of the vaccine to prevent infectiousness as well as the impact on outcomes based on the timing of distribution and the potential effects of waning immunity. FINDINGS: Increased vaccine efficacy against disease reduces hospitalizations and deaths from COVID-19; however, the relative benefit of transmission blocking varied depending on the timing of vaccine distribution. Early in an outbreak, a vaccine that reduces transmission will be relatively more effective than one introduced later in the outbreak. In addition, earlier and accelerated implementation of a less effective vaccine is more impactful than later implementation of a more effective vaccine. These findings are magnified when considering the durability of the vaccine. Vaccination in the spring will be less impactful when immunity is less durable. INTERPRETATION: Policy choices regarding non-pharmaceutical interventions, such as social distancing and face mask use, will need to remain in place longer if the vaccine is less effective at reducing transmission or distributed slower. In addition, the stage of the local outbreak greatly impacts the overall effectiveness of the vaccine in a region and should be considered when allocating vaccines. FUNDING: Centers for Disease Control and Prevention (CDC) MInD-Healthcare Program (U01CK000589, 1U01CK000536), James S. McDonnell Foundation 21st Century Science Initiative Collaborative Award in Understanding Dynamic and Multiscale Systems, National Science Foundation (CNS-2027908), National Science Foundation Expeditions (CCF1917819), C3.ai Digital Transformation Institute (AWD1006615), and Google, LLC. |
format | Online Article Text |
id | pubmed-8072137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-80721372021-04-26 Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality Haghpanah, Fardad Lin, Gary Levin, Simon A. Klein, Eili EClinicalMedicine Research Paper BACKGROUND: COVID-19 vaccines have been approved and made available. While questions of vaccine allocation strategies have received significant attention, important questions remain regarding the potential impact of the vaccine given uncertainties regarding efficacy against transmission, availability, timing, and durability. METHODS: We adapted a susceptible-exposed-infectious-recovered (SEIR) model to examine the potential impact on hospitalization and mortality assuming increasing rates of vaccine efficacy, coverage, and administration. We also evaluated the uncertainty of the vaccine to prevent infectiousness as well as the impact on outcomes based on the timing of distribution and the potential effects of waning immunity. FINDINGS: Increased vaccine efficacy against disease reduces hospitalizations and deaths from COVID-19; however, the relative benefit of transmission blocking varied depending on the timing of vaccine distribution. Early in an outbreak, a vaccine that reduces transmission will be relatively more effective than one introduced later in the outbreak. In addition, earlier and accelerated implementation of a less effective vaccine is more impactful than later implementation of a more effective vaccine. These findings are magnified when considering the durability of the vaccine. Vaccination in the spring will be less impactful when immunity is less durable. INTERPRETATION: Policy choices regarding non-pharmaceutical interventions, such as social distancing and face mask use, will need to remain in place longer if the vaccine is less effective at reducing transmission or distributed slower. In addition, the stage of the local outbreak greatly impacts the overall effectiveness of the vaccine in a region and should be considered when allocating vaccines. FUNDING: Centers for Disease Control and Prevention (CDC) MInD-Healthcare Program (U01CK000589, 1U01CK000536), James S. McDonnell Foundation 21st Century Science Initiative Collaborative Award in Understanding Dynamic and Multiscale Systems, National Science Foundation (CNS-2027908), National Science Foundation Expeditions (CCF1917819), C3.ai Digital Transformation Institute (AWD1006615), and Google, LLC. Elsevier 2021-04-26 /pmc/articles/PMC8072137/ /pubmed/33937734 http://dx.doi.org/10.1016/j.eclinm.2021.100863 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Paper Haghpanah, Fardad Lin, Gary Levin, Simon A. Klein, Eili Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality |
title | Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality |
title_full | Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality |
title_fullStr | Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality |
title_full_unstemmed | Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality |
title_short | Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality |
title_sort | analysis of the potential impact of durability, timing, and transmission blocking of covid-19 vaccine on morbidity and mortality |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072137/ https://www.ncbi.nlm.nih.gov/pubmed/33937734 http://dx.doi.org/10.1016/j.eclinm.2021.100863 |
work_keys_str_mv | AT haghpanahfardad analysisofthepotentialimpactofdurabilitytimingandtransmissionblockingofcovid19vaccineonmorbidityandmortality AT lingary analysisofthepotentialimpactofdurabilitytimingandtransmissionblockingofcovid19vaccineonmorbidityandmortality AT levinsimona analysisofthepotentialimpactofdurabilitytimingandtransmissionblockingofcovid19vaccineonmorbidityandmortality AT kleineili analysisofthepotentialimpactofdurabilitytimingandtransmissionblockingofcovid19vaccineonmorbidityandmortality |